Who backs VeraDermics (NYS: MANE)?
26 investors| Investor | Type |
|---|---|
| Viking Global Investors | Asset manager |
| Connecticut Innovations | Venture capital |
| The Invus Group | PE / buyout |
| Osage University Partners | Venture capital |
| Marshall Wace | Hedge fund |
| SR One Capital Management | Other |
| Longitude Capital | Venture capital |
| Surveyor Capital | Hedge fund |
| Columbia Management | Asset manager |
| Suvretta Capital Management | Hedge fund |
| + 16 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for VeraDermics (NYS: MANE)
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 26 firms already write checks for companies like VeraDermics (NYS: MANE) in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.